Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearside Biomedical

0.7928
-0.0072-0.90%
Post-market: 0.80990.0171+2.16%18:18 EDT
Volume:110.82K
Turnover:89.27K
Market Cap:61.61M
PE:-1.94
High:0.8194
Open:0.7900
Low:0.7900
Close:0.8000
Loading ...

Clearside Biomedical Announces Multiple Presentations to Be Featured at the Clinical Trials at the Summit Meeting

THOMSON REUTERS
·
17 Jun

Clearside Biomedical Inc. Conducted Annual Stockholders Meeting

Reuters
·
31 May

Clearside Biomedical Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
23 May

Clearside Biomedical price target lowered to $5 from $6 at H.C. Wainwright

TIPRANKS
·
23 May

Clearside Biomedical Price Target Maintained With a $5.00/Share by JMP Securities

Dow Jones
·
17 May

Citizens JMP Keeps Their Buy Rating on Clearside Biomedical (CLSD)

TIPRANKS
·
16 May

Clearside Biomedical Reports Q1 2025 Financial Progress

TIPRANKS
·
16 May

Clearside Biomedical Is Maintained at Buy by Needham

Dow Jones
·
15 May

Clearside Biomedical Inc : Needham Cuts Target Price to $3 From $4

THOMSON REUTERS
·
15 May

Clearside Biomedical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Clearside Biomedical Q1 EPS $(0.11), Inline, Sales $2.33M Beat $170.00K Estimate

Benzinga
·
15 May

Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
13 May

Clearside Biomedical announces six presentations related to CLS-AX

TIPRANKS
·
09 May

Clearside Biomedical Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
05 May

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire
·
01 May

Clearside Biomedical Price Target Maintained With a $4.00/Share by Needham

Dow Jones
·
08 Apr

Clearside Biomedical Inc (CLSD) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
02 Apr

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
01 Apr

Clearside Biomedical Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Mar

Stifel Nicolaus Sticks to Its Buy Rating for Clearside Biomedical (CLSD)

TIPRANKS
·
29 Mar